Apellis Pharmaceuticals Inc. (1JK)

20.67500 EUR

0.235

1.12%

Last update Dec 18, 8:04 AM CET

Market closed

Day range

20.67500

Previous close

20.91000

Open

20.67500

Access this stock data via API

Apellis Pharmaceuticals Inc.

20.68

0.24

1.12%

Revenue estimate	Current quarter (Dec 2025)	Next quarter (Mar 2026)	Current year (Dec 2025)	Next year (Dec 2026)
Number of Analysts	18	10	19	19
Avg. estimate	201.11M	193.29M	990.98M	871.07M
Low estimate	184.60M	174M	698.26M	787.62M
High estimate	232.40M	208.50M	1.05B	955M
Last year sales	212.53M	166.80M	781.37M	990.98M
Sales growth	-0.05	0.16	0.27	-0.12

Access /revenue_estimate data via our API — starting from the Ultra plan.

EPS revisions	Current quarter (Dec 2025)	Next quarter (Mar 2026)	Current year (Dec 2025)	Next year (Dec 2026)
Up last 7 days	0	0	0	0
Up last 30 days	0	0	0	0
Down last 7 days	0	0	0	0
Down last 30 days	0	0	0	0

Access /eps_revisions data via our API — starting from the Ultra plan.

Access /recommendations data via our API — starting from the Ultra plan.

Access /analyst_ratings/light data via our API — starting from the Ultra plan.

Apellis Pharmaceuticals Inc.